Clin2
NCT06066268Possibly a fitRecruiting

miRNAs in Critical Limb Ischemia Study

Critical Limb Ischemia

Part of Heart & circulation clinical trials.

This study looks at small molecules called miRNAs in the blood of people with severe leg artery disease (critical limb ischemia) or belly aortic aneurysm. The goal is to find patterns that may help doctors better understand and treat these conditions.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
40 years to 85 years
Study type
Observational

Who can take part

  • You have critical limb ischemia (CLI) and are scheduled for leg bypass surgery or a major amputation, OR you have an abdominal aortic aneurysm (AAA) and are scheduled for a non-surgical repair (EVAR).
  • You are not pregnant.
  • You do not have a genetic disease or active cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04312451Recruiting
Study of severe leg blood-flow problems after a procedure

This study follows adults with very poor blood flow to the foot or leg (with wounds or severe pain) who are having a revascularization procedure to improve circulation. It may help doctors understand outcomes after treatment and improve care for people with critical limb ischemia.

Paris
NCT06795620Not yet recruiting· Phase 1
Stem cell treatment for severe leg artery disease

This trial tests whether injecting stem cells from donated fat tissue can help people with severe blockages in leg arteries who cannot have surgery or angioplasty. The goal is to see if the treatment is safe and if it can improve blood flow and reduce pain or wounds.

Toulouse, France
NCT06174597Recruiting· Early Phase 1
Stem cells for critical limb ischemia treatment

This trial tests whether stem cells from umbilical cord arteries can help people with severe leg pain or ulcers due to blocked arteries. It is for those who cannot have surgery or other procedures.

Nanjing, Jiangsu
NCT06482892Recruiting· Phase 2
Testing a new drug for severe leg artery disease

This trial tests an experimental drug for people with critical limb ischemia, a serious condition where not enough blood reaches the legs. It aims to see if the drug can help with pain or healing of leg ulcers without the need for surgery.

Suzhou, Jiangsu
NCT06296576Recruiting
Testing a new way to predict critical limb ischemia

This trial uses a Doppler ultrasound to measure blood flow speed in your leg arteries to see if it can better predict a severe form of peripheral artery disease called critical limb ischemia. You may qualify if you have known artery disease in your leg and are already scheduled for a toe blood pressure test.

Cholet
NCT06277362Recruiting
New Leg-Saving Treatment for Critical Limb Ischemia

This study tests a new way to restore blood flow to the leg in people who have wounds or dead tissue on their foot and have run out of other treatment options. It's for those who have already tried angioplasty twice without success or have severely hardened small arteries.

Ancona, Ancona

Hear when a new Critical Limb Ischemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.